Advances in immunotherapyfor prostate cancer

This publication has 92 references indexed in Scilit:

• Prostate cancer immunotherapy at the dawn of the new millennium
  Expert Opinion on Investigational Drugs, 2000
• Mycobacterium vaccae (SRL172): a potential immunological adjuvant evaluated in rat prostate cancer
  British Journal of Urology, 1998
• In Vitro Generation of Human Cytotoxic T Lymphocytes Specific for Peptides Derived From Prostate-Specific Antigen
  JNCI Journal of the National Cancer Institute, 1997
• A Mechanism for the Specific Immunogenicity of Heat Shock Protein-Chaperoned Peptides
  Science, 1995
• MUC‐1 Epithelial Tumor Mucin‐Based Immunity and Cancer Vaccines
  Immunological Reviews, 1995
• Heterodimerization and functional interaction between EGF receptor family members: a new signaling paradigm with implications for breast cancer research
  Breast Cancer Research and Treatment, 1995
• Role of Bone Marrow-Derived Cells in Presenting MHC Class I-Restricted Tumor Antigens
  Science, 1994
• Vaccination with cytotoxic T lymphocyte epitope‐containing peptide protects against a tumor induced by human papillomavirus type 16‐transformed cells
  European Journal of Immunology, 1993
• Restoration of Viral Immunity in Immunodeficient Humans by the Adoptive Transfer of T Cell Clones
  Science, 1992
• Establishment and characterization of seven dunning rat prostatic cancer cell lines and their use in developing methods for predicting metastatic abilities of prostatic cancers
  The Prostate, 1986